NRX Pharmaceuticals, Inc. (NASDAQ:NRXP) filed a Form 8-K with the Securities and Exchange Commission on February 02, 2026, disclosing a material event.
NRX Pharmaceuticals, Inc.'s stock currently trades at $2.15 with a market capitalization of $37.9M. The Healthcare company's stock moved following the disclosure.


